http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002530649-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2828 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 1999-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002530649-A |
| titleOfInvention | Immunoassay for determining infectious spongiform encephalopathy in mammals |
| abstract | (57) [Summary]nThe present invention relates to an immunoassay for measuring prion protein (PrP) in body tissue or body fluid samples from non-bovine mammals, the method being intended to facilitate its extraction and binding to antibodies. Applying PrP obtained from the above step to a) a capturing antibody bound or bindable to a solid phase; and b) applying a detection antibody to the PrP obtained from the step; and detecting the PrP bound to the solid phase. Quantifying the signal from the antibody for use. Further, the present invention relates to a method for diagnosing infectious spongiform encephalopathy (TSE) in a mammal, the method comprising: It relates to a method of screening to determine whether or not it is infected. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4667453-B2 |
| priorityDate | 1998-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.